| Evaluation of the Intestinal Microbiota and Bacterial Translocation in Patients With Rheumatoid Arthritis (NCT01961310) | Centre Hospitalier Universitaire de Nīmes | 2016-03-08 |
| Comparative and Pragmatic Study of Golimumab Intravenous (IV) (Simponi Aria) Versus Infliximab (Remicade) in Rheumatoid Arthritis (NCT02728934) | Janssen Scientific Affairs, LLC | 2016-02-25 |
| The Influence of Rapid Recovery on Sleep Quality Following Total Knee Replacement Surgery (NCT02845960) | Southwest Hospital, China | 2016-02-01 |
| Long-term Assessment of Safety and Efficacy of BI 695501 in Patients With Rheumatoid Arthritis (NCT02640612) | Boehringer Ingelheim | 2016-01-22 |
| Assessment of the Handling Experience With the BI 695501 Autoinjector in Patients With Rheumatoid Arthritis Followed by an Extension Phase Using BI 695501 Prefilled Syringe (NCT02636907) | Boehringer Ingelheim | 2016-01-06 |
| Supporting Patient Care With Electronic Resource (SuPER) (NCT02540044) | University of British Columbia | 2016-01-01 |
| Inhibition of Co-Stimulation in Rheumatoid Arthritis (NCT02652273) | NHS Greater Glasgow and Clyde | 2016-01-01 |
| Effectiveness of Bazedoxifene for Prevention of Glucocorticoid-induced Bone Loss in RA Patients (NCT02602704) | Hanyang University | 2015-12-29 |
| Characterization of Breg Cells (NCT02615951) | University Hospital, Montpellier | 2015-10-02 |
| Identification of Epigenetic Biomarkers for Early Detection of Rheumatic Disease (NCT02742337) | Arthritis Northwest PLLC | 2015-10-01 |
| Comparison of Compliance and Evolution of Functional Capacity of Patients With Rheumatoid Arthritis Treated by Methotrexate Either by Auto-injector or by Conventional Sub-cutaneous Syringe (NCT02553018) | Nordic Pharma SAS | 2015-09-01 |
| A Study to Assess Inflammation in Rheumatoid Arthritis Using Molecular Imaging Techniques (NCT02350426) | GlaxoSmithKline | 2015-08-12 |
| Safety and Tolerability Study of MBS2320 in Healthy Subjects and Subjects With Rheumatoid Arthritis (NCT02480946) | Modern Biosciences Ltd | 2015-07-01 |
| A Study to Compare FKB327 Long-term Safety, Efficacy and Immunogenicity With Humira® in Rheumatoid Arthritis Patients (NCT02405780) | Fujifilm Kyowa Kirin Biologics Co., Ltd. | 2015-06-10 |
| Do Inflammatory Arthritis Inpatients Receiving Group Music Therapy Improve Pain Compared to Music Listening? (NCT02436785) | University of British Columbia | 2015-05-06 |
| Screening Protein Markers in Patients With Rheumatoid Arthritis and Hot-dampness and Blood Stasis Syndrome (NCT02408094) | Guang'anmen Hospital of China Academy of Chinese Medical Sciences | 2015-05-01 |
| Identification of New Biomarkers to Promote Personalized Treatment of Patients With Inflammatory Rheumatic Diseases (NCT03214263) | Rigshospitalet, Denmark | 2015-05-01 |
| Cardiovascular Risk and Chronic Inflammatory Rheumatism (NCT03187444) | University Hospital, Clermont-Ferrand | 2015-04-24 |
| 6-Month Phase I/II Open Label PRTX-100 in Previous Rheumatoid Arthritis Study Participants and Sera Collection (NCT02330445) | Protalex, Inc. | 2015-02-01 |
| Follow-up of Person-centered Care of Young Adults With Rheumatic Disease (NCT02402894) | Vastra Gotaland Region | 2015-02-01 |
| A Study Comparing LBEC0101 to Enbrel® in Subjects With Active Rheumatoid Arthritis Despite Methotrexate Therapy (NCT02357069) | LG Life Sciences | 2015-02-01 |
| BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis (NCT02137226) | Boehringer Ingelheim | 2015-01-26 |
| The Efficacy and Safety of Tacrolimus in Refractory Rheumatoid Arthritis Patients for 6 Months and Long-term Treatment (NCT02837978) | Qiang Shu | 2015-01-01 |
| Home Monitoring of Patients With Chronic Diseases - an eRehab Test-retest Study (NCT02316977) | Eva Ejlersen Wæhrens | 2014-12-01 |
| A Study to Compare FKB327 Efficacy and Safety With Humira® in Rheumatoid Arthritis Patients (NCT02260791) | Fujifilm Kyowa Kirin Biologics Co., Ltd. | 2014-12-01 |
| Wireless Motion Sensors for Rheumatoid Arthritis Patients - Pilot Study (NCT02296632) | Cedars-Sinai Medical Center | 2014-11-01 |
| Treat-to-target in RA: Collaboration To Improve adOption and adhereNce (NCT02260778) | Brigham and Women's Hospital | 2014-09-01 |
| Characterization of the Effect of Tocilizumab in Vivo and in Vitro on T Follicular Helper Cells in Rheumatoid Arthritis Patients and Consequence on B Cells Maturation (NCT02569736) | Association Aquitaine de Recherche Clinique en Rhumatologie | 2014-09-01 |
| Rheumatoid Arthritis and Treatment of Periodontitis: a Randomized Clinical Trial. (NCT05271890) | University of Pisa | 2014-08-25 |
| A Study of E6011 in Japanese Subjects With Rheumatoid Arthritis (NCT02196558) | Eisai Co., Ltd. | 2014-05-26 |
| Zoledronic Acid in Rheumatoid Arthritis (NCT02123264) | Carmen Gómez-Vaquero | 2014-05-01 |
| Uncontrolled Study to Evaluate Efficacy of Tocilizumab in Patients With Moderate or Severe Rheumatoid Arthritis (NCT02087696) | Spanish Foundation of Rheumatology | 2014-05-01 |
| A Study Comparing Sirukumab (CNTO 136) Monotherapy With Adalimumab (HUMIRA®) Monotherapy in the Treatment of Active Rheumatoid Arthritis (NCT02019472) | Janssen Research & Development, LLC | 2014-04-04 |
| Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis (NCT02114931) | Amgen | 2014-04-01 |
| Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis (NCT02092467) | Pfizer | 2014-03-14 |
| T and B Cell Responses in Autoimmune Diseases (NCT01947036) | National Institute of Allergy and Infectious Diseases (NIAID) | 2014-01-01 |
| Efficacy and Safety Study of ABP 501 Compared to Adalimumab in Subjects With Moderate to Severe Rheumatoid Arthritis (NCT01970475) | Amgen | 2013-10-01 |
| Immunogenicity and Safety of Vaccinations in Immunocompromised Persons (NCT01947465) | University of Zurich | 2013-10-01 |
| A Golimumab Phase 3b, Multicenter, Assessment of Intravenous Efficacy in Rheumatoid Arthritis Subjects Who Have Diminished Disease Control Despite Treatment With Infliximab (REMICADE®) (NCT01962974) | Janssen Biotech, Inc. | 2013-10-01 |
| This Study is Randomised, Single Oral Dose Bioequivalence Study of Meloxicam GSK 15 MG Tablets. (NCT01750931) | GlaxoSmithKline | 2013-09-12 |
| Phase 1 Dose Escalating Study to Assess Safety, Tolerability, Food Effect and PK of CHR-5154 in Healthy Male Volunteers (NCT01934101) | GlaxoSmithKline | 2013-08-12 |
| Long-term Safety and Efficacy of Sirukumab in Participants With RA Completing Studies CNTO136ARA3002 or CNTO136ARA3003 (NCT01856309) | Janssen Research & Development, LLC | 2013-08-07 |
| Clinical Study to Evaluate the Efficacy of Anakinra in Patients With Rheumatoid Arthritis and Diabetes (NCT02236481) | Prof. Roberto Giacomelli | 2013-07-01 |
| Study of the Influence of the Expression of the Calcium-sensitive Receptor (CaSR) by Monocytes in the Synovial Liquid on Structural Alterations in Patients Diagnosed With Rheumatoid Arthritis in the Previous Two Years (NCT02894047) | Centre Hospitalier Universitaire, Amiens | 2013-07-01 |
| Exercise Training in Patients With Rheumatoid Arthritis and Cryotherapy (NCT02855801) | Centre Hospitalier Universitaire de Besancon | 2013-06-01 |
| Neuromusuclar Adaptations in the Rheumatoid Arthritis Disease (NCT03543488) | Federal University of Rio Grande do Sul | 2013-06-01 |
| Safety and Efficacy of BI 695500 in Patients With Moderately to Severely Active Rheumatoid Arthritis (NCT01955733) | Boehringer Ingelheim | 2013-05-31 |
| Evolution of Adipokines and Body Composition in Rheumatoid Arthritis Patients Receiving Tocilizumab Therapy (NCT02843789) | Centre Hospitalier Universitaire de Besancon | 2013-03-01 |
| A Long-term Safety Extension Study of Tocilizumab in Brazilian Participants With Rheumatoid Arthritis (RA) Who Completed the Studies ML21530 and MA21488 (NCT01715831) | Hoffmann-La Roche | 2013-01-15 |
| Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Clinical Effects of Multiple Rising Subcutaneous Doses of BI 655064 in Healthy Volunteers and in Rheumatoid Arthritis Patients With Prior Inadequate Response to Methotrexate Therapy (NCT01751776) | Boehringer Ingelheim | 2012-12-18 |
| A Study of CNTO 136 (Sirukumab) Administered Subcutaneously in Japanese Patients With Active Rheumatoid Arthritis Unresponsive to Methotrexate or Sulfasalazine (NCT01689532) | Janssen Pharmaceutical K.K. | 2012-11-01 |
| Preliminary Study of Sonic Hedgehog Signaling Pathway in the Pathogenesis of Rheumatoid Arthritis (NCT01731262) | Third Affiliated Hospital, Sun Yat-Sen University | 2012-11-01 |
| Safety Study of PRTX-100 With Methotrexate or Leflunomide to Treat Active Rheumatoid Arthritis (NCT01749787) | Protalex, Inc. | 2012-11-01 |
| A Study to Evaluate the Effect of a Single Dose of CNTO 136 (Sirukumab) on CYP450 Enzyme Activities After Subcutaneous Administration in Patients With Rheumatoid Arthritis (NCT01636557) | Janssen Research & Development, LLC | 2012-10-11 |
| A Study to Evaluate the Long-term Safety and Efficacy of ASP015K in Subjects Previously Enrolled in a Phase 2 ASP015K Rheumatoid Arthritis Study (NCT01711814) | Astellas Pharma Global Development, Inc. | 2012-09-26 |
| Efficacy, Pharmacokinetics, and Safety of BI 695500 in Patients With Rheumatoid Arthritis (NCT01682512) | Boehringer Ingelheim | 2012-09-05 |
| A Study of CNTO 136 (Sirukumab), Administered Subcutaneously, in Patients With Active Rheumatoid Arthritis Despite Disease-Modifying Antirheumatic Drug (DMARD) Therapy (SIRROUND-D) (NCT01604343) | Janssen Research & Development, LLC | 2012-08-15 |
| A Study of CNTO 136 (Sirukumab), a Human Anti-IL-6 Monoclonal Antibody, Administered Subcutaneously, in Patients With Active Rheumatoid Arthritis Despite Anti-TNF-Alpha Therapy (SIRROUND-T) (NCT01606761) | Janssen Research & Development, LLC | 2012-08-06 |
| A Study of the Effectiveness and Safety of Ustekinumab (STELARA) and CNTO 1959 Administered Under the Skin of Patients With Active Rheumatoid Arthritis, Despite Existing Methotrexate Therapy (NCT01645280) | Janssen Research & Development, LLC | 2012-08-01 |
| A Study to Evaluate the Safety and Efficacy of ASP015K in Moderate to Severe Rheumatoid Arthritis Subjects Who Have Had an Inadequate Response to Methotrexate (NCT01554696) | Astellas Pharma Inc | 2012-07-06 |
| A Study of JNJ-40346527 in Patients With Active Rheumatoid Arthritis Despite Disease-modifying Antirheumatic Drug Therapy (NCT01597739) | Janssen Research & Development, LLC | 2012-07-01 |
| Effectiveness and Safety of Physical Exercises in the Improvement of the Sleep Quality. Regarding Rheumatoid Arthritis (NCT01919645) | Federal University of São Paulo | 2012-07-01 |
| A Study to Evaluate the Safety and Efficacy of ASP015K in Moderate to Severe Rheumatoid Arthritis (NCT01565655) | Astellas Pharma Global Development, Inc. | 2012-06-19 |
| A Study to Continue ASP015K Treatment to Rheumatoid Arthritis Patients Who Completed Phase IIb Study or Phase III Study of ASP015K (NCT01638013) | Astellas Pharma Inc | 2012-06-13 |
| Efficacy and Safety of Tripterygium Wilfordii in Patients With Rheumatoid Arthritis (NCT01613079) | Peking Union Medical College Hospital | 2012-05-01 |
| Topical Tripterygium Wilfordii Gel for Moderate Activity Rheumatoid Arthritis (NCT02818361) | Guang'anmen Hospital of China Academy of Chinese Medical Sciences | 2012-04-01 |
| A Study To Evaluate The Effect Of CP-690,550 On Measures Of Kidney Function In Patients With Active Rheumatoid Arthritis (NCT01484561) | Pfizer | 2012-04-01 |
| An MRI-guided Treatment Strategy to Prevent Disease Progression in Patients With Rheumatoid Arthritis (NCT01656278) | Professor of Rheumatology, MD, DMSci, Kim Horslev-Petersen | 2012-03-01 |
| Real-world Clinical Efficacy of Abatacept in the T3 Data Registry (NCT01555879) | Arthritis Northwest PLLC | 2012-03-01 |
| A Study of the Effect of Supervised Exercise Programme in Patients With Rheumatoid Arthritis (NCT01553305) | Aarhus University Hospital | 2012-01-01 |
| Oral Baricitinib (LY3009104)Treatment in Japanese Participants With Active Rheumatoid Arthritis on Background Methotrexate Therapy (NCT01469013) | Eli Lilly and Company | 2011-11-01 |
| Benefit of Orthopedic Navigation in the ARThroplasty of the Hip (NCT01496300) | Aesculap AG | 2011-11-01 |
| Assessment of the Disease Severity and Treatment Patterns of Rheumatoid Arthritis in Eastern Europe, Middle East and North African Countries (P08167) (NCT01313871) | Merck Sharp & Dohme LLC | 2011-08-01 |
| Detection of Pathological Lymphocytes in Patients With Autoimmune Disease (NCT02813083) | University of Minnesota | 2011-08-01 |
| A Relative Bioavailability and Food Effect Study of New Formulations (NCT01398475) | Eli Lilly and Company | 2011-07-01 |
| Long Term Effects of an Early Response to Certolizumab Pegol (CZP, Cimzia®) in Rheumatoid Arthritis (RA) Patients (NCT01288287) | UCB Pharma | 2011-07-01 |
| Ultrasound Evaluation of Hands in Patients With Systemic Lupus Erythematosus (NCT01471301) | Federal University of São Paulo | 2011-06-01 |
| Ultrasound Utility in Routine Clinical Practise (NCT03124225) | Barts & The London NHS Trust | 2011-06-01 |
| A Study to Evaluate the Effectiveness of Infliximab and Changes in Hand and Wrist Magnetic Resonance Imaging (MRI) in Participants With Active Rheumatoid Arthritis (RA) (P08136) (NCT01313520) | Merck Sharp & Dohme LLC | 2011-03-01 |
| A Study To Compare The Amount Of CP-690,550 That Is Absorbed Into The Blood Of Healthy Subjects Following Oral Administration Of Two Different Strength Tablets Of CP-690,550 (NCT01277991) | Pfizer | 2011-02-01 |
| Milnacipran in the Treatment of Widespread, Non-Joint Pain in Rheumatoid Arthritis (NCT01207453) | Brigham and Women's Hospital | 2011-01-01 |
| A Study in Participants With Rheumatoid Arthritis on Background Methotrexate Therapy (NCT01185353) | Eli Lilly and Company | 2010-10-01 |
| Pain Modulation in Rheumatoid Arthritis (RA) - Influence of Adalimumab (NCT01197144) | Karolinska Institutet | 2010-10-01 |
| A Two-Part, 12-Week Study of Etoricoxib as a Treatment for Rheumatoid Arthritis (RA) (MK-0663-107) (NCT01208181) | Organon and Co | 2010-09-27 |
| Pain Inhibition in Patients With Rheumatoid Arthritis and Central Sensitivity Syndromes (NCT01154647) | Vrije Universiteit Brussel | 2010-09-01 |
| Concomitant Use of Apremilast for the Treatment of Active RA Despite TNF-Inhibition and Methotrexate- CATARA (NCT01204138) | Stanford University | 2010-09-01 |
| Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients (NCT01211678) | Biogen | 2010-06-01 |
| Repeat Dose Subcutaneous Rhumatoid Arthritis Efficacy Study (NCT01101555) | GlaxoSmithKline | 2010-05-12 |
| Safety, Pharmacodynamics and Pharmacokinetics of GSK2136525 Repeat Dose in Rheumatoid Arthritis (NCT01077531) | GlaxoSmithKline | 2010-04-28 |
| Articular Sonography: Healthy Subjects Versus Rheumatoid Arthritis Patients (NCT01476865) | Federal University of São Paulo | 2010-03-01 |
| A Study Of The Taste Of Different Oral Liquid Preparations Of CP-690,550 In Trained Adult Product Testers (NCT01023100) | Pfizer | 2010-03-01 |
| A Study to Investigate the Ability of GSK706769 to Maintain Clinical Remission After Withdrawal of Enbrel in Rheumatoid Arthritis Patients (NCT00979771) | GlaxoSmithKline | 2010-02-01 |
| Comparing The Effectiveness And Safety Of 2 Doses Of An Experimental Drug, CP-690,550, To Methotrexate (MTX) In Patients With Rheumatoid Arthritis Who Have Not Previously Received MTX (NCT01039688) | Pfizer | 2010-01-01 |
| Study of CP-690,550 Versus Placebo In Rheumatoid Arthritis Patients On Background Methotrexate With Inadequate Response To Tumor Necrosis Factor (TNF) Inhibitors (NCT00960440) | Pfizer | 2009-10-01 |
| Efficacy of Aquamantys for Reducing Transfusions With Anterior Supine Intermuscular Approach Total Hip Arthroplasty (NCT01583465) | Joint Implant Surgeons, Inc. | 2009-10-01 |
| Subcutaneous Golimumab (GLM) Plus DMARDs for Rheumatoid Arthritis, Followed by Intravenous/Subcutaneous GLM Strategy (P06129 AM2) (NCT00975130) | Merck Sharp & Dohme LLC | 2009-09-01 |
| An Effectiveness and Safety Study of Intravenous Golimumab in Patients With Active Rheumatoid Arthritis Despite Treatment With Methotrexate Therapy (NCT00973479) | Centocor, Inc. | 2009-09-01 |
| Study Evaluating Etanercept Plus Methotrexate in Early Rheumatoid Arthritis (NCT00913458) | Pfizer | 2009-09-01 |
| A Study Comparing 2 Doses Of CP-690,550 Vs. Placebo For The Treatment Of Rheumatoid Arthritis In Patients On Other Background Arthritis Medications (NCT00856544) | Pfizer | 2009-05-01 |
| Vitamin D Deficiency Causes Immune Dysfunction and Enables or Perpetuates the Development of Rheumatoid Arthritis (NCT00279461) | Indiana University | 2009-05-01 |